Serious Shortage Protocols ( SSP's )

In February 2019, the Human Medicines Regulations 2012 were amended to introduce Serious Shortage Protocols (SSPs).

 Further changes will come into operation on 31 October 2019 in The Pharmaceutical Services (Amendments Relating to Serious Shortage Protocols) Regulations (Northern Ireland) 2019. 

An SSP enables community pharmacists to supply a specified medicine in accordance with a protocol rather than a prescription and without the need to seek authorisation from the prescriber.  An SSP would only be used in the case of a serious shortage if it is considered that it would help manage the supply situation.

Further information on SSPs will be made available on this page.   

 Last updated: 24th May 2022

 

Serious Shortage Protocol Guidance

Serious Shortage Protocol Archive

 

HRT SSPs Flowchart 

Letter from CPO - Updated SSPs - HRT Medicines  8th June 2022

Letter from CPO Regarding SSP - Hormone Replacement Therapy (HRT) Medication 24.05.22

Serious Shortage Protocol - SSP022

Serious Shortage Protocol - SSP023

Serious Shortage Protocol - SSP024

Serious Shortage Protocol - SSP025

Serious Shortage Protocol - SSP026

Serious Shortage Protocol - SSP027

Serious Shortage Protocol - SSP028

Serious Shortage Protocol - SSP029

Serious Shortage Protocol - SSP030

Serious Shortage Protocol - SSP031

 

Letter from CPO Regarding SSP - Hormone Replacement Therapy (HRT) Medication  May 2022
SSP019 Serious Shortage Protocol (SSP) Oestrogel Pump-Pack 0.06% gel  May 2022
SSP020 Serious Shortage Protocol (SSP) Ovestin 1mg cream  May 2022
SSP021 Serious Shortage Protocol (SSP) Premique Low Dose 0.3mg/1.5mg MR tablets  May 2022

 

Letter from Cathy Harrison (CPO) - Ending of SSP - Fluoxetine 40mg capsules  May 2021